Samah Ahmed

Samah Ahmed

Auto-generated profile, based on publicly available information

Samah Ahmed

Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences University of Manitoba Winnipeg Manitoba Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
HOHoucemeddine Othman
Houcemeddine Othman
LZLyndon Zass
Lyndon Zass
JRJorge E. B. da Rocha
Jorge E. B. da Rocha
Fouzia RadouaniFouzia Radouani
Fouzia Radouani
CSChaimae Samtal
Chaimae Samtal
Samar Kamal KassimSamar Kamal Kassim
Samar Kamal Kassim
Genomics data are currently being produced at unprecedented rates, resulting in increased knowledge discovery and submission to public data repositories. Despite these advances, genomic information on African-ancestry populations remains significantly low compared with European- and Asian-ancestry populations. This information is typically segmented across several different biomedical data repositories, which often lack sufficient fine-grained structure and annotation to account for the diversity of African populations, leading to many challenges related to the retrieval, representation and findability of such information. To overcome these challenges, we developed the African Genomic Medicine Portal (AGMP), a database that contains metadata on genomic medicine studies conducted on African-ancestry populations. The metadata is curated from two public databases related to genomic medicine, PharmGKB and DisGeNET. The metadata retrieved from these source databases were limited to genomic variants that were associated with disease aetiology or treatment in the context of African-ancestry populations. Over 2000 variants relevant to populations of African ancestry were retrieved. Subsequently, domain experts curated and annotated additional information associated with the studies that reported the variants, including geographical origin, ethnolinguistic group, level of association significance and other relevant study information, such as study design and sample size, where available. The AGMP functions as a dedicated resource through which to access African-specific information on genomics as applied to health research, through querying variants, genes, diseases and drugs. The portal and its corresponding technical documentation, implementation code and content are publicly available.

1 January 2023 in Global Health, Epidemiology and Genomics
Verified
Journal Article
Open access
PDF file
LZLyndon Zass
Lyndon Zass
KJKatherine Johnston
Katherine Johnston
ABAlia Benkahla
Alia Benkahla
MCMelek Chaouch
Melek Chaouch
JKJudit kumuthini
Judit kumuthini
NMNicola Mulder
Nicola Mulder
Modern biomedical research is characterised by its high‐throughput and interdisciplinary nature. Multiproject and consortium‐based collaborations requiring meaningful analysis of multiple heterogeneous phenotypic datasets have become the norm; however, such analysis remains a challenge in many regions across the world. An increasing number of data harmonisation efforts are being undertaken by multistudy collaborations through either prospective standardised phenotype data collection or retrospective phenotype harmonisation. In this regard, the Phenotype Harmonisation Working Group (PHWG) of the Human Heredity and Health in Africa (H3Africa) consortium aimed to facilitate phenotype standardisation by both promoting the use of existing data collection standards (hosted by PhenX), adapting existing data collection standards for appropriate use in low‐ and middle‐income regions such as Africa, and developing novel data collection standards where relevant gaps were identified. Ultimately, the PHWG produced 11 data collection kits, consisting of 82 protocols, 38 of which were existing protocols, 17 were adapted, and 27 were novel protocols. The data collection kits will facilitate phenotype standardisation and harmonisation not only in Africa but also across the larger research community. In addition, the PHWG aims to feed back adapted and novel protocols to existing reference platforms such as PhenX.

14 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
JRJorge da Rocha
Jorge da Rocha
HOHoucemeddine Othman
Houcemeddine Othman
GBGerrit Botha
Gerrit Botha
LCLaura Cottino
Laura Cottino
DTDavid Twesigomwe
David Twesigomwe
ACas members of the H3Africa Consortium
as members of the H3Africa Consortium
Investigating variation in genes involved in the absorption, distribution, metabolism , and excretion (ADME) of drugs are key to characterising pharmacogenomic (PGx) relationships. ADME gene variation is relatively well characterised in European and Asian populations, but African populations are under-studied – which has implications for safe and effective drug use in Africa. The genetic diversity of ADME genes across sub-Saharan African populations is large. The Southern African population cluster is most distinct from that of far West Africa. PGx strategies based on European variants will be of limited use in African populations. Although established variants are important, PGx must take into account the full range of African variation. This work urges further characterisation of variants in African populations including in vitro and in silico studies, and to consider the unique African ADME landscape when developing precision medicine guidelines and tools for African populations. Author summary: The ADME genes are a group of genes that play a key role in absorption, distribution, metabolism and excretion of drugs. Variations in these genes can have a significant impact on drug safety and efficacy. Africa has a high level of genetic variation and is under-studied in drug development, which makes study of variations in these genes in African populations very important. Using a new data set of 458 high-coverage genomes from across Africa, we characterise the extent and impact of variation in the ADME genes, looking at both single nucleotide and copy number variations. We identified 343,368 variants, including 40,692 novel variants, and 930 coding variants which are predicted to have high impact on function. Our discovery curves indicate that there will be considerable value in sequencing more African genomes. Moreover, relatively few of these novel variants are captured on common genotyping arrays. We show that there is considerable diversity within Africa in some important genes, and this will have significant consequences for the emerging field of precision medicine in Africa.

13 December 2023 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
DMDeanne Nixie R. Miao
Deanne Nixie R. Miao
FLFeryal Ladha
Feryal Ladha
SLSarah M. Lyle
Sarah M. Lyle
DODaniel Wilhelm Olivier
Daniel Wilhelm Olivier
SASamah Ahmed
Samah Ahmed
BDBritt Drogemoller
Britt Drogemoller